ITCI - Intra-Cellular Therapies, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ITCI (1567514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
32 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2019-01-04
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$11.58-52,2021,138,707-4%-$604,310
DM
2019-01-04
ITCIHalstead MichaelEVP, GCS - Sale+OE$11.58-24,566191-99%-$284,418
DM
2019-01-04
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$11.58-24,56615,832-61%-$284,383
DM
2019-01-04
ITCIVanover Kimberly E.SVP, Early Stage Clinical Dev.S - Sale+OE$11.52-10,15627,068-27%-$116,979
D
2019-01-04
ITCIDavis Robert ESVP, Chief Scientific OfficerS - Sale+OE$11.46-9,56443,989-18%-$109,630
D
2019-01-02
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$11.09-17,4781,184,305-1%-$193,831
D
2019-01-02
ITCIHalstead MichaelEVP, GCS - Sale+OE$11.09-7,80721,649-27%-$86,580
D
2019-01-02
ITCIVanover Kimberly E.SVP, Early Stage Clinical Dev.S - Sale+OE$11.10-4,83435,670-12%-$53,657
D
2019-01-02
ITCIDavis Robert ESVP, Chief Scientific OfficerS - Sale+OE$11.11-4,83453,553-8%-$53,706
D
2019-01-02
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$11.09-7,80738,490-17%-$86,580
D
2018-12-06
ITCIDavis Robert ESVP, Chief Scientific OfficerS - Sale+OE$13.53-89930,256-3%-$12,163
M
2018-11-09
ITCIMarcus Joel SDirS - Sale$18.17-32,0001,291,569-2%-$581,580
M
2018-02-15
ITCIHineline Lawrence J.VP of Finance CFOS - Sale$20.02-49,70017,032-74%-$995,165
2018-01-22
ITCIHalstead MichaelSVP, GCS - Sale$18.03-25,500191-99%-$459,765
2018-01-08
ITCIVanover Kimberly E.SVP, Clinical DevelopmentS - Sale$17.46-77212,373-6%-$13,479
2018-01-08
ITCIMates SharonCOB, Pres, CEOS - Sale$17.48-6,6041,088,707-1%-$115,438
D
2018-01-05
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$17.08-11,2571,095,311-1%-$192,270
D
2018-01-05
ITCIVanover Kimberly E.SVP, Clinical DevelopmentS - Sale+OE$17.37-1,18513,145-8%-$20,583
D
2018-01-04
ITCIDavis Robert ESVP, Chief Scientific OfficerS - Sale+OE$15.60-1,11529,397-4%-$17,394
DM
2018-01-04
ITCIHineline Lawrence J.VP of Finance CFOS - Sale+OE$16.34-5,06266,732-7%-$82,725
DM
2018-01-04
ITCIHalstead MichaelSVP, GCS - Sale+OE$16.39-4,22025,691-14%-$69,179
2017-12-29
ITCIVan Nostrand Robert LDirP - Purchase$14.48+3453,656+10%+$4,996
2017-12-29
ITCIRiggs Rory BDirP - Purchase$14.48+1,001263,2780%+$14,494
2017-12-29
ITCILerner Richard ADirP - Purchase$14.48+94962,570+2%+$13,742
2017-12-29
ITCIAlafi Christopher DDir, 10%P - Purchase$14.48+1,0015,202,4900%+$14,494
D
2017-12-11
ITCILerner Richard ADirS - Sale+OE$15.09-7,00061,621-10%-$105,630
D
2017-12-05
ITCIDavis Robert ESVP, Chief Scientific OfficerS - Sale+OE$15.00-65027,864-2%-$9,750
2017-11-22
ITCIAlafi Christopher DDir, 10%P - Purchase$15.55+10,0005,201,4890%+$155,500
D
2017-10-30
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$15.75-18,7501,088,707-2%-$295,313
2017-10-02
ITCIAlafi Moshe10%P - Purchase$15.50+258,0653,953,270+7%+$4,000,008
2017-10-02
ITCIAlafi Christopher DDir, 10%P - Purchase$15.50+258,0655,191,489+5%+$4,000,008
2017-10-02
ITCIAlafi Capital Co LLC10%P - Purchase$15.50+258,0653,953,270+7%+$4,000,008
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top